Laboratory Corporation of America Holdings (LabCorp) to Offer a New Companion Diagnostic for Non-Small Cell Lung Cancer

October 4, 2011 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today the nationwide availability of a new FDA-approved companion diagnostic for lung cancer patients.

Twitter
LinkedIn
Facebook
Email
Print